ID IL27B_HUMAN Reviewed; 229 AA. AC Q14213; O75269; DT 24-MAY-2004, integrated into UniProtKB/Swiss-Prot. DT 24-MAY-2004, sequence version 2. DT 24-NOV-2009, entry version 78. DE RecName: Full=Interleukin-27 subunit beta; DE Short=IL-27 subunit beta; DE Short=IL-27B; DE AltName: Full=Epstein-Barr virus-induced gene 3 protein; DE Short=EBV-induced gene 3 protein; DE Flags: Precursor; GN Name=EBI3; Synonyms=IL27B; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], INDUCTION, GLYCOSYLATION, AND INTERACTION RP WITH SQSTM1. RC TISSUE=B-cell; RX MEDLINE=96135230; PubMed=8551575; RA Devergne O., Hummel M., Koeppen H., Le Beau M.M., Nathanson E.C., RA Kieff E., Birkenbach M.; RT "A novel interleukin-12 p40-related protein induced by latent Epstein- RT Barr virus infection in B lymphocytes."; RL J. Virol. 70:1143-1153(1996). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15057824; DOI=10.1038/nature02399; RA Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., RA Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., RA Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., RA Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M., RA Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., RA Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M., RA Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T., RA Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H., RA Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S., RA Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J., RA Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M., RA Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J., RA Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D., RA Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A., RA Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I., RA Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E., RA Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M., RA Rubin E.M., Lucas S.M.; RT "The DNA sequence and biology of human chromosome 19."; RL Nature 428:529-535(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Pancreas; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP FUNCTION, AND SUBUNIT. RX PubMed=12121660; DOI=10.1016/S1074-7613(02)00324-2; RA Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., RA Hibbert L., Churakova T., Travis M., Vaisberg E., Blumenschein W.M., RA Mattson J.D., Wagner J.L., To W., Zurawski S., McClanahan T.K., RA Gorman D.M., Bazan J.F., de Waal Malefyt R., Rennick D., RA Kastelein R.A.; RT "IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, RT induces proliferation of naive CD4(+) T cells."; RL Immunity 16:779-790(2002). RN [5] RP REVIEW. RX PubMed=17294231; DOI=10.1007/s00109-007-0164-7; RA Batten M., Ghilardi N.; RT "The biology and therapeutic potential of interleukin 27."; RL J. Mol. Med. 85:661-672(2007). CC -!- FUNCTION: Cytokine with pro- and anti-inflammatory properties, CC that can regulate T helper cell development, suppress T-cell CC proliferation, stimulate cytotoxic T cell activity, induce isotype CC switching in B-cells, and that has diverse effects on innate CC immune cells. Among its target cells are CD4 T helper cells which CC can differentiate in type 1 effector cells (TH1), type 2 effector CC cells (TH2) and IL17 producing helper T-cells (TH17). It drives CC rapid clonal expansion of naive but not memory CD4 T-cells. It CC also strongly synergizes with IL-12 to trigger interferon- CC gamma/IFN-gamma production of naive CD4 T-cells, binds to the CC cytokine receptor WSX-1/TCCR. Another important role of IL27 is CC its antitumor activity as well as its antiangiogenic activity with CC activation of production of antiangiogenic chemokines. CC -!- SUBUNIT: Heterodimer with IL27. IL-27 is an heterodimer composed CC IL27 and EBI3. EBI3 is also a component of the IL-12 heterodimer. CC Interacts with SQSTM1. CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- INDUCTION: By EBV. CC -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 3 CC subfamily. CC -!- SIMILARITY: Contains 2 fibronectin type-III domains. CC -!- WEB RESOURCE: Name=Wikipedia; Note=Interleukin-27 entry; CC URL="http://en.wikipedia.org/wiki/Interleukin_27"; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; L08187; AAA93193.1; -; mRNA. DR EMBL; AC005578; AAC33488.1; -; Genomic_DNA. DR EMBL; BC015364; AAH15364.1; -; mRNA. DR EMBL; BC046112; AAH46112.1; -; mRNA. DR IPI; IPI00034088; -. DR RefSeq; NP_005746.2; -. DR UniGene; Hs.501452; -. DR IntAct; Q14213; 1. DR STRING; Q14213; -. DR PRIDE; Q14213; -. DR Ensembl; ENST00000221847; ENSP00000221847; ENSG00000105246; Homo sapiens. DR GeneID; 10148; -. DR KEGG; hsa:10148; -. DR UCSC; uc002lzu.1; human. DR CTD; 10148; -. DR GeneCards; GC19P004180; -. DR H-InvDB; HIX0014656; -. DR HGNC; HGNC:3129; EBI3. DR MIM; 605816; gene. DR PharmGKB; PA27584; -. DR HOGENOM; Q14213; -. DR HOVERGEN; Q14213; -. DR OMA; YPVAVDC; -. DR OrthoDB; EOG9ZGRZ2; -. DR Pathway_Interaction_DB; il27pathway; IL27-mediated signaling events. DR NextBio; 38403; -. DR ArrayExpress; Q14213; -. DR Bgee; Q14213; -. DR CleanEx; HS_EBI3; -. DR Genevestigator; Q14213; -. DR GermOnline; ENSG00000105246; Homo sapiens. DR GO; GO:0005615; C:extracellular space; TAS:ProtInc. DR GO; GO:0005886; C:plasma membrane; TAS:ProtInc. DR GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW. DR GO; GO:0004896; F:cytokine receptor activity; IPI:UniProtKB. DR GO; GO:0006959; P:humoral immune response; TAS:ProtInc. DR GO; GO:0046641; P:positive regulation of alpha-beta T cell pr...; TAS:UniProtKB. DR GO; GO:0045078; P:positive regulation of interferon-gamma bio...; TAS:UniProtKB. DR GO; GO:0042088; P:T-helper 1 type immune response; TAS:UniProtKB. DR InterPro; IPR008957; Fibronectin_typ-III-like_fold. DR InterPro; IPR003961; FN_III. DR InterPro; IPR003530; Hematopoietin_rcpt_L_F3_CS. DR Gene3D; G3DSA:2.60.40.30; FN_III-like; 1. DR Pfam; PF00041; fn3; 1. DR SMART; SM00060; FN3; 2. DR PROSITE; PS50853; FN3; 2. DR PROSITE; PS01354; HEMATOPO_REC_L_F3; 1. PE 1: Evidence at protein level; KW Complete proteome; Cytokine; Glycoprotein; Polymorphism; Repeat; KW Secreted; Signal. FT SIGNAL 1 20 Potential. FT CHAIN 21 229 Interleukin-27 subunit beta. FT /FTId=PRO_0000010937. FT DOMAIN 24 124 Fibronectin type-III 1. FT DOMAIN 129 221 Fibronectin type-III 2. FT CARBOHYD 55 55 N-linked (GlcNAc...) (Potential). FT CARBOHYD 105 105 N-linked (GlcNAc...) (Potential). FT VARIANT 174 174 A -> V (in dbSNP:rs1803524). FT /FTId=VAR_049171. FT VARIANT 201 201 V -> I (in dbSNP:rs4740). FT /FTId=VAR_024342. FT CONFLICT 144 145 QL -> HV (in Ref. 1; AAA93193). SQ SEQUENCE 229 AA; 25396 MW; CFBAD72D91859EF0 CRC64; MTPQLLLALV LWASCPPCSG RKGPPAALTL PRVQCRASRY PIAVDCSWTL PPAPNSTSPV SFIATYRLGM AARGHSWPCL QQTPTSTSCT ITDVQLFSMA PYVLNVTAVH PWGSSSSFVP FITEHIIKPD PPEGVRLSPL AERQLQVQWE PPGSWPFPEI FSLKYWIRYK RQGAARFHRV GPIEATSFIL RAVRPRARYY VQVAAQDLTD YGELSDWSLP ATATMSLGK //